Abstract
Combination therapy has proven to be an effective strategy for treating many of the world's most intractable diseases. A growing number of investigators in academia, industry, regulatory agencies, foundations and advocacy organizations are interested in pursuing a combination approach to treating Alzheimer's disease. A meeting co-hosted by the Accelerate Cure/Treatments for Alzheimer's Disease Coalition, the Critical Path Institute and the Alzheimer's Association addressed challenges in designing clinical trials to test multiple treatments in combination and outlined a roadmap for making such trials a reality.
Original language | English (US) |
---|---|
Pages (from-to) | 327-333 |
Number of pages | 7 |
Journal | Expert Review of Neurotherapeutics |
Volume | 15 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2015 |
Keywords
- Alzheimer' disease
- co-development
- collaboration
- combination therapy
- novel therapy
ASJC Scopus subject areas
- General Neuroscience
- Clinical Neurology
- Pharmacology (medical)